Senior Lecturer on Medicine, Brigham and Women's Hospital
Cardiology
Dr. David P. Faxon, MD
|
|
Give Review
David P. Faxon practices Cardiology. He graduated from Boston University School of Medicine. Boston University School of Medicine has a rank of 30 in research and a 52 in primary care He over the years received 2 awards: "Fellow (FACC)" and "Whos Who in Medicine and Healthcare". Doctor David P. Faxon, MD has written publications. He has 65 publications published with PubMed. The lastest paper is: 'Can BRIGHT Restore the Glow of Bivalirudin?' David Faxon accepts Medicare payments and is listed with Medicare.gov.
Publications
- Can BRIGHT Restore the Glow of Bivalirudin?
- The great taboo of non-infarct-related artery revascularization during primary percutaneous Coronary intervention.
- Benefit of Long-Term Dual Anti-Platelet Therapy in Patients Treated With Drug-Eluting Stents: From the NHLBI Dynamic Registry.
- How to manage antiplatelet therapy for stenting in a patient requiring oral anticoagulants.
- Transcatheter Aortic valve replacement: History and current status.
- Very late stent thrombosis: current concepts.
- Very Late Stent Thrombosis and Late Target Lesion Revascularization: No End in Sight.
- Transcatheter Aortic valve implantation: coming of age.
- Comparison of Three Age Groups Regarding Safety and Efficacy of Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic Registry).
- Antithrombotic therapy in patients with atrial fibrillation undergoing Coronary stenting: a north american perspective: executive summary.
- Revascularization of left main Coronary artery disease.
- Optimizing antiplatelet therapy in Acute coronary syndrome and percutaneous coronary intervention.
- Meta-Analysis of Multivessel Coronary Artery Revascularization Versus Culprit-Only Revascularization in Patients With ST-Segment Elevation Myocardial Infarction and Mu...
- Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous Coronary intervention (from the National Heart, Lung and B...
- Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous Coronary intervention in the National Heart, Lung, and Blood Institute dyna...
- Percutaneous Coronary intervention of moderate to severe calcified Coronary lesions: insights from the National Heart, Lung, and Blood Institute Dynamic Registry.
- Coronary intervention in patients with Acute coronary syndrome: does every culprit lesion require revascularization?
- Examining treatment of ST-elevation Myocardial infarction: the importance of early intervention.
- Women are like men ... Sometimes.
- Efficacy and safety of fondaparinux versus enoxaparin in patients with Acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: resul...
- The many costs of bleeding.
- Facts and controversies of aspirin and clopidogrel therapy.
- Percutaneous Coronary intervention for myocardial infarction with left ventricular dysfunction.
- ACC/AHA 2008 Guideline update on valvular heart Disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Associ...
- Assessing appropriateness of Coronary angiography: another step in improving quality.
- Circulation: cardiovascular interventions: keeping pace with progress.
- New data on early management of patients with ST-elevation Myocardial infarction.
- Prevention of intravenous contrast-induced nephropathy in hospital inpatients.
- Task force 1: training in clinical cardiology.
- Efficacy and safety of fondaparinux versus enoxaparin in patients with Acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5...
- ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/A...
- Development of systems of care for ST-elevation Myocardial infarction patients: executive summary.
- Development of systems of care for ST-elevation Myocardial infarction patients: current state of ST-elevation Myocardial infarction care.
- ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures a report of the American College of Cardiology Foundation/American ...
- Strategies to improve early reperfusion in ST-elevation Myocardial infarction.
- The CHARISMA trial and the REACH registry outcomes.
- Facilitated percutaneous Coronary intervention.
- Left main Coronary revascularization at the crossroads.
- Antiplatelet therapy in populations at high risk of atherothrombosis.
- Antithrombotic agents. Fondaparinux in Acute coronary syndromes: improved efficacy and safety.
- Coronary interventions and their impact on post myocardial infarction survival.
- Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel Coronary intervention.
- Coronary artery disease in patients with Buerger's disease.
- Use of antiplatelet agents and anticoagulants for cardiovascular Disease: current standards and best practices.
- Critical GI issues for the cardiologist: new insights and understanding. Introduction.
- ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Ta...
- Beta-blocker therapy and primary angioplasty: what is the controversy?
- Bringing reality to drug-eluting stents.
- Coronary artery compression caused by a large pseudoaneurysm complicating an Acute myocardial infarction.
- Current advances in the diagnosis and treatment of renal Artery stenosis.
- From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
- From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.
- ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Asso...
- Need for centers to care for patients with Acute coronary syndromes.
- Percutaneous Coronary intervention in women.
- Systemic drug therapy for restenosis: "déjà vu all over again".
- Improved outcomes for women undergoing contemporary percutaneous Coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registry.
- ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery--Executive Summary. A report of the American College of Cardiology/American...
- The chain of scientific discovery: the critical role of the physician-scientist.
- Update on radiation for restenosis.
- Current anticoagulation options in percutaneous intervention: designing patient-specific strategies.
- Revascularization in diabetes: have stents made a difference?
- Is Primary Angioplasty the Best Treatment for AMI in the Elderly?
- Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for Coronary artery disease: mixed treatment comparison meta-anal...
Schools
Boston University School Of Medicine
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
- Whos Who in Medicine and Healthcare
Education
-
Boston University Medical Center -
Dartmouth-Hitchcock Medical Center -
Boston University School of Medicine
Hospital
-
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1770681017 | |
| NPPES Provider LastName | FAXON | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 021201613 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 245.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1770681017 |
| Last Name Of The Provider | FAXON |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Ami B. Bhatt, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter J. Zimetbaum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pradeep Natarajan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Praveen K. Rao, MD |
|
|
Dr. Michelle A. Albert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ara L. Tachjian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lynn Punnoose, MD |
|
|
Dr. Chirag R. Barbhaiya, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter Libby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley M. Lewis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew P. Coggins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yonathan F. Melman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheldon M. Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hanna K. Gaggin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stafford I. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy E. Spooner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elad Anter, MD
This Doctor is OpenDoctor Recommended.
|